Latest court orders, judgments, and legal developments from Indian courts — AI-curated and summarized.
FeaturedCalcutta and Delhi High Courts are divided on whether non-use cancellation under Section 47 triggers 'rectification proceedings' under Section 124 of the Trade Marks Act. This split affects stay applications in infringement suits.
FeaturedThe Delhi High Court in ZARA v. ZORA held that a formal declaration of well-known status under Rule 124 is not mandatory to invoke Section 11(2) protections. The ruling enables litigants to establish well-known status through evidence in individual cases.
FeaturedIPO’s Draft Guidelines for Examination of Pharmaceutical Patent Applications, 2026, face sharp criticism for misquoting statutory provisions and misinterpreting Section 3(d) of the Patents Act. Experts warn the draft could undermine patent stability and prosecution consistency if adopted without revision.
FeaturedThe Indian Patent Office’s Draft Guidelines for Examination of Pharmaceutical Patent Applications (2026) face strong criticism for misquoting statutory provisions and misinterpreting legal standards. Stakeholders call for substantial revision before finalization.
FeaturedThe Delhi High Court, in Fresenius Kabi v. Controller, set aside the rejection of a patent application for Sugammadex, citing procedural flaws under Section 14 of the Patents Act. The Court criticized the use of hindsight and mosaicking in prior art analysis.
FeaturedThe Delhi High Court set aside the Controller’s refusal of Fresenius Kabi’s Sugammadex patent, citing procedural flaws under Section 14 of the Patents Act. The order underscores strict compliance with hearing requirements and warns against hindsight bias in inventive step analysis.
FeaturedThe Kerala High Court is concluding the final hearing on the Ribociclib litigation, a pivotal case in pharmaceutical patent law. The outcome may have significant implications for access to medicines in India.
FeaturedThe Delhi High Court is addressing the complexities of personality rights with recent rulings indicating a new approach. This marks a potential shift in how personality rights are interpreted and enforced in India.
FeaturedIn Columbia Pictures Industries, Inc. v. Registrar of TMs, the Delhi High Court ruled that well-known trademarks enjoy protection even against dissimilar goods. This pivotal decision broadens the scope of trademark protection in India.
FeaturedThe Kerala High Court is set to conduct the final hearing in the long-standing Ribociclib patent litigation today. The outcome could have significant implications for the pharmaceutical industry, particularly regarding access to cancer treatments.
FeaturedThe Delhi High Court's ruling in Hindustan Unilever Limited v. Kwick Living illuminates the complexities of territorial jurisdiction in internet-related disputes. The decision outlines the applicable principles, highlighting the need for clarity in jurisdictional criteria as digital commerce expands.
FeaturedThis week’s SpicyIP review highlights significant developments including new AI patent guidelines from the Patent Office, key copyright rulings by the Calcutta High Court, and implications for practitioners. Notably, the decisions in IPRS v. Hotel Appolo and the Thaler-Dabus case are set to impact how copyrights and patents are navigated in light of technological advancements.